| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042827763 |
| P356 | DOI | 10.1007/S11154-014-9308-6 |
| P698 | PubMed publication ID | 25557611 |
| P5875 | ResearchGate publication ID | 270397557 |
| P50 | author | Natalie A. Sims | Q38324957 |
| P2093 | author name string | T John Martin | |
| P2860 | cites work | WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk | Q21090209 |
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis | Q24324701 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation | Q74411385 | ||
| Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers | Q74488802 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Control of RANKL gene expression | Q24619669 | ||
| Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice | Q24642117 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif | Q28138697 | ||
| Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 | ||
| Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis | Q28141482 | ||
| Matrix-embedded cells control osteoclast formation | Q28247746 | ||
| Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 | ||
| The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily | Q28291317 | ||
| Denosumab in postmenopausal women with low bone mineral density | Q28298728 | ||
| Heritable disorders of the RANKL/OPG/RANK signaling pathway | Q28299674 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Q29619487 | ||
| Cells of bone: proliferation, differentiation, and hormonal regulation | Q34182637 | ||
| Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus | Q34335512 | ||
| Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation | Q34339627 | ||
| Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis | Q34369482 | ||
| Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts | Q34409480 | ||
| Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation | Q34424720 | ||
| Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures | Q34560491 | ||
| A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss | Q34567407 | ||
| Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner | Q34998618 | ||
| Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures | Q35360217 | ||
| Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. | Q35913646 | ||
| Modulation of osteoclast differentiation | Q35957509 | ||
| Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations | Q36005508 | ||
| Osteoclast-derived activity in the coupling of bone formation to resorption. | Q36032429 | ||
| Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts | Q36352137 | ||
| Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity | Q36636031 | ||
| Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling | Q36695575 | ||
| Dissociation between bone resorption and bone formation in osteopenic transgenic mice | Q36800774 | ||
| Commitment to the osteoblast lineage is not required for RANKL gene expression | Q37176364 | ||
| Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time | Q37227675 | ||
| Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit | Q37506724 | ||
| Advances in the biology of bone metastasis: how the skeleton affects tumor behavior | Q37774077 | ||
| Osteoclast-derived coupling factors in bone remodeling | Q38108750 | ||
| Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. | Q38296222 | ||
| Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo | Q38329281 | ||
| Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 | ||
| The pathobiology of the osteoclast | Q39492910 | ||
| Biochemical Characterization with Parathormone and Calcitonin of Isolated Bone Cells: Provisional Identification of Osteoclasts and Osteoblasts | Q40007256 | ||
| Cell proliferation and specialization during endochondral osteogenesis in young rats | Q41043295 | ||
| Role of osteoblasts in hormonal control of bone resorption—A hypothesis | Q41551873 | ||
| Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. | Q41700823 | ||
| Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells | Q41713781 | ||
| Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice | Q43493548 | ||
| Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. | Q43597885 | ||
| Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption | Q44590734 | ||
| Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin | Q44639831 | ||
| Familial expansile osteolysis | Q45287088 | ||
| Increased presence of capillaries next to remodeling sites in adult human cancellous bone. | Q45881370 | ||
| EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis. | Q46284330 | ||
| Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
| Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. | Q51788770 | ||
| Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. | Q52172979 | ||
| Osteoclast-like cell formation in fetal and newborn long-term baboon marrow cultures is more sensitive to 1,25-dihydroxyvitamin D3 than adult long-term marrow cultures. | Q52255684 | ||
| Osteoblastic cells are involved in osteoclast formation. | Q54374668 | ||
| EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. | Q54470749 | ||
| Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. | Q54528928 | ||
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| Investigation of cell lineage in bone using a chimaera of chick and quail embryonic tissue | Q59094872 | ||
| Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases | Q62392239 | ||
| Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen Cells | Q66903767 | ||
| The osteoclast: review of ultrastructure, origin, and structure-function relationship | Q67832252 | ||
| Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures | Q68274092 | ||
| Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption | Q68737372 | ||
| The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells | Q69541163 | ||
| The cellular basis of bone resorption | Q71328791 | ||
| Role of osteoblasts in hormonal control of bone resorption - a hypothesis | Q71614035 | ||
| Activated T lymphocytes support osteoclast formation in vitro | Q73149439 | ||
| Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function | Q74244387 | ||
| P433 | issue | 2 | |
| P921 | main subject | physiology | Q521 |
| P304 | page(s) | 131-139 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Reviews in Endocrine and Metabolic Disorders | Q15766899 |
| P1476 | title | RANKL/OPG; Critical role in bone physiology | |
| P478 | volume | 16 |
| Q64107402 | A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats |
| Q91521103 | Antiresorptive and anabolic agents in the prevention and reversal of bone fragility |
| Q61448534 | BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signaling |
| Q38673908 | Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases. |
| Q57490079 | Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption |
| Q91712822 | CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation |
| Q49500472 | Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma |
| Q26825199 | Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis |
| Q98945602 | Compounds isolated from Euonymus spraguei Hayata induce ossification through multiple pathways |
| Q88661756 | Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A |
| Q59051790 | Coupling of bone resorption and formation by RANKL reverse signalling |
| Q37604094 | Does Oxidative Stress Induced by Alcohol Consumption Affect Orthodontic Treatment Outcome? |
| Q64265660 | EGFR Signaling: Friend or Foe for Cartilage? |
| Q33894857 | Evaluation of Osteogenesis and Angiogenesis of Icariin in Local Controlled Release and Systemic Delivery for Calvarial Defect in Ovariectomized Rats |
| Q48034150 | Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety |
| Q50045416 | Gene expression profiles in dental follicles from patients with impacted canines. |
| Q38743436 | High-density lipoprotein (HDL) metabolism and bone mass |
| Q64118016 | Hypoxia-inducible factor 2α is a negative regulator of osteoblastogenesis and bone mass accrual |
| Q64084531 | Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration |
| Q51417792 | LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation. |
| Q51364696 | Lipopolysaccharide increases IL-6 secretion via activation of the ERK1/2 signaling pathway to up-regulate RANKL gene expression in MLO-Y4 cells. |
| Q46256338 | Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation |
| Q92962201 | Melatonin prevents bone destruction in mice with retinoic acid-induced osteoporosis |
| Q47118982 | Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity |
| Q42508259 | Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab |
| Q44730444 | MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway |
| Q37034768 | Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats |
| Q58711955 | Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation |
| Q91863478 | OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D |
| Q33577344 | RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening |
| Q61442944 | Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy |
| Q39369106 | Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients |
| Q61136132 | SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix |
| Q37641079 | Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes |
| Q64890772 | Study on site-specific expression of bone formation and resorption factors in human dental follicles. |
| Q47095137 | Substrate Microarchitecture Shapes the Paracrine Crosstalk of Stem Cells with Endothelial Cells and Osteoblasts. |
| Q41550017 | TGF-β2-induced ANGPTL4 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone |
| Q92050583 | The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"? |
| Q58766844 | The Use of Pulsed Electromagnetic Fields to Promote Bone Responses to Biomaterials and |
| Q36356014 | The effects of chosen plant extracts and compounds on mesenchymal stem cells-a bridge between molecular nutrition and regenerative medicine- concise review. |
| Q41995909 | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis |
| Q51256674 | Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer. |
| Q91393746 | Western-type diet differentially modulates osteoblast, osteoclast, and lipoblast differentiation and activation in a background of APOE deficiency |
| Q95402467 | [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63] |
Search more.